Know Cancer

or
forgot password

A Feasibility Study of the Effects of a Directed Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

A Feasibility Study of the Effects of a Directed Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation


Inclusion Criteria:



- Patients will be eligible if they have any of the following surgical procedures
performed by an attending on the Breast Service:

SLNB alone Axillary lymph node dissection (ALND) alone Total Mastectomy TM (+/-
reconstruction) with SLNB or ALND Breast conserving therapy (BCT) with SLNB or ALND

- Age > 18 years

- Planned to undergo adjuvant post-operative chemotherapy with or without radiation at
MSKCC and have not yet started chemotherapy

Exclusion Criteria:

- Undergoing TM or BCT without SLNB

- Having had prior breast cancer treated with surgery

- Unable to participate in a exercise program related to other medical problems

- More than 8 weeks post surgery.

- Having a concurrent cancer in addition to breast cancer

- Who have had any type of chemotherapy in the past two years

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To evaluate compliance with and demonstrate the feasibility of an at-home, directed exercise program during adjuvant chemotherapy and radiation (if applicable).

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Alexandra Heerdt, MD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

10-062

NCT ID:

NCT01157767

Start Date:

May 2010

Completion Date:

May 2014

Related Keywords:

  • Breast Cancer
  • exercise
  • lymphedema
  • post-operative chemotherapy
  • post-operative radiation
  • 10-062
  • Breast Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021